← Human Trials & Peer-Reviewed Studies
Survival of multiple-surface ART restorations using a zinc-reinforced glass-ionomer restorative after 2 years: A randomized triple-blind clinical trial.
Plain-language guide to PMID 31235189 (2019): parallel-group randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 218 participants.
Key Facts
- PMID
- 31235189
- Journal
- Dental materials : official publication of the Academy of Dental Materials
- Year
- 2019
- Study type
- Randomized Controlled Trial
- Authors
- Mobarak E et al. (10 authors)
- DOI
- 10.1016/j.dental.2019.05.012
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
Who Took Part
According to the abstract, 218 participants were involved.
The age groups tagged for this paper are teenagers.
A total of 218 participants, average age 15.4 years (SD=0.2), with an occluso-proximal carious lesion in a permanent (pre-) molar were included.
How the Study Was Run
In design terms this was a randomized and parallel-group study.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
Groups ran in parallel: each of the participants stayed in one arm throughout.
A randomized triple-blind parallel group clinical trial was used.
Restorations using test (ChemFil Rock) and control (Fuji IX GP) restoratives were placed according to the ART method by four calibrated operators.
Restoration survival curves were estimated using the Kaplan-Meier method and difference between dependent and independent variables tested with a Wald (chi-square) test.
What Was Measured
PubMed files the paper under topics including Dental Caries, Dental Restoration, Permanent, Glass Ionomer Cements, Molar, Tooth and Zinc.
Author keywords: Atraumatic Restorative Treatment, ChemFil Rock, Fuji IX GP, Multiple surface restorations, Occluso-proximal restorations and Permanent teeth.
What This Means in Plain Language
The paper is a randomized and parallel-group study of Vitamin D, K2, Magnesium and Zinc in 218 participants.
Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2019 (Dental materials : official publication of the Academy of Dental Materials), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.